We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FCA Free Speech Defense Tested In DOJ-PhRMA Fight

Law360, New York (September 19, 2014, 2:24 PM EDT) -- A fiery feud in California federal court between the U.S. Department of Justice and Pharmaceutical Research and Manufacturers of America shows the gloves are finally off in a fight that will shape the future of False Claims Act litigation, experts say, with opposing sides clashing over whether the First Amendment always shields honest off-label promotion.

The battle playing out in recent weeks in Solis v. Millennium comes almost two years after the Second Circuit’s monumental Caronia ruling, which erased a pharmaceutical salesman’s misbranding conviction after finding he’d been...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.